Androgen‐targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer

BACKGROUND: Prostate cancer and multiple neurodegenerative diseases (NDD) share an age‐associated pattern of onset. Therapy of prostate cancer is known to impact cognitive function. The objective of this study was to determine the impact of multiple classes of androgen‐targeting therapeutics (ATT) o...

Descripción completa

Detalles Bibliográficos
Autores principales: Branigan, Gregory L., Torrandell‐Haro, Georgina, Soto, Maira, Gelmann, Edward P., Vitali, Francesca, Rodgers, Kathleen E., Brinton, Roberta Diaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249980/
https://www.ncbi.nlm.nih.gov/pubmed/35293700
http://dx.doi.org/10.1002/cam4.4650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249980/
https://www.ncbi.nlm.nih.gov/pubmed/35293700
http://dx.doi.org/10.1002/cam4.4650

Ejemplares similares